Education
About Us
Working with TipRanks
Follow Us
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
2348 Stock Chart & Stats
HK$1.23
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.23
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.07 - HK$1.47
Previous CloseN/A
Volume344.00K
Average Volume (3M)355.07K
Market Cap
HK$1.85B
Enterprise ValueHK$339.51M
Total Cash (Recent Filing)HK$1.62B
Total Debt (Recent Filing)HK$9.16M
Price to Earnings (P/E)9.7
Beta0.33
Next Earnings
Mar 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.12%
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,503,357,000
10 Day Avg. Volume239,600
30 Day Avg. Volume355,066
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.52
Price to Sales (P/S)1.63
P/FCF Ratio38.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dawnrays Pharmaceutical Holdings Ltd. News
2348 FAQ
What was Dawnrays Pharmaceutical Holdings Ltd.’s price range in the past 12 months?
Dawnrays Pharmaceutical Holdings Ltd. lowest stock price was HK$1.07 and its highest was HK$1.47 in the past 12 months.
What is Dawnrays Pharmaceutical Holdings Ltd.’s market cap?
Dawnrays Pharmaceutical Holdings Ltd.’s market cap is HK$1.85B.
When is Dawnrays Pharmaceutical Holdings Ltd.’s upcoming earnings report date?
Dawnrays Pharmaceutical Holdings Ltd.’s upcoming earnings report date is Mar 20, 2026 which is in 87 days.
How were Dawnrays Pharmaceutical Holdings Ltd.’s earnings last quarter?
Dawnrays Pharmaceutical Holdings Ltd. released its earnings results on Aug 22, 2025. The company reported HK$0.075 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.075.
Is Dawnrays Pharmaceutical Holdings Ltd. overvalued?
According to Wall Street analysts Dawnrays Pharmaceutical Holdings Ltd.’s price is currently Overvalued.
Does Dawnrays Pharmaceutical Holdings Ltd. pay dividends?
Dawnrays Pharmaceutical Holdings Ltd. pays a Annually dividend of HK$0.015 which represents an annual dividend yield of 5.12%. See more information on Dawnrays Pharmaceutical Holdings Ltd. dividends here
What is Dawnrays Pharmaceutical Holdings Ltd.’s EPS estimate?
Dawnrays Pharmaceutical Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dawnrays Pharmaceutical Holdings Ltd. have?
Dawnrays Pharmaceutical Holdings Ltd. has 1,503,357,000 shares outstanding.
What happened to Dawnrays Pharmaceutical Holdings Ltd.’s price movement after its last earnings report?
Dawnrays Pharmaceutical Holdings Ltd. reported an EPS of HK$0.075 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.781%.
Which hedge fund is a major shareholder of Dawnrays Pharmaceutical Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2348
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dawnrays Pharmaceutical Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.03%
12-Months-Change
Fundamentals
Return on Equity
5.34%
Trailing 12-Months
Asset Growth
-2.12%
Trailing 12-Months
Company Description
Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Sihuan Pharmaceutical Holdings Group
―
Consun Pharmaceutical Group Ltd.
―
Jacobson Pharma Corporation Limited
―
China Shineway Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---